A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhan...
Uloženo v:
| Vydáno v: | Journal of the American Heart Association Ročník 11; číslo 24; s. e027363 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
John Wiley and Sons Inc
20.12.2022
Wiley |
| Témata: | |
| ISSN: | 2047-9980, 2047-9980 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in
, which encodes cardiovascular K
(ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed
variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m
in CS, n=30; 26.6 [24.1-32.8] g/m
in controls, n=17;
<0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17;
=0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17;
=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure. |
|---|---|
| AbstractList | Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in ABCC9, which encodes cardiovascular KATP (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m2 in CS, n=30; 26.6 [24.1-32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure.Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in ABCC9, which encodes cardiovascular KATP (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m2 in CS, n=30; 26.6 [24.1-32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure. Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high‐output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high‐output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain‐of‐function variants in ABCC9, which encodes cardiovascular KATP (ATP‐sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3–32 years], body mass index 19.9 [16.5–22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7–103.0] g/m2 in CS, n=30; 26.6 [24.1–32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90–103] mm Hg in CS, n=17; 109 [98–115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56–66] mm Hg in CS, n=17; 69 [65–72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long‐term follow‐up. Conclusions The data define the natural history of high‐output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long‐term consequences of high‐output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high‐output heart failure. Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in , which encodes cardiovascular K (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m in CS, n=30; 26.6 [24.1-32.8] g/m in controls, n=17; <0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; =0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; =0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure. |
| Author | Nichols, Colin G. Aggarwal, Manish Gu, Hongjie Remedi, Maria S. Singh, Gautam K. McClenaghan, Conor Grange, Dorothy K. |
| AuthorAffiliation | 2 Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO 4 Division of Statistics Washington University School of Medicine St. Louis MO 1 Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO 3 Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO 5 Department of Medicine, Division of Endocrinology Washington University School of Medicine St. Louis MO 6 Department of Pediatrics, Division of Genetics Washington University School of Medicine St. Louis MO |
| AuthorAffiliation_xml | – name: 4 Division of Statistics Washington University School of Medicine St. Louis MO – name: 3 Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO – name: 5 Department of Medicine, Division of Endocrinology Washington University School of Medicine St. Louis MO – name: 6 Department of Pediatrics, Division of Genetics Washington University School of Medicine St. Louis MO – name: 2 Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO – name: 1 Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO |
| Author_xml | – sequence: 1 givenname: Gautam K. surname: Singh fullname: Singh, Gautam K. organization: Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO, Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO – sequence: 2 givenname: Conor orcidid: 0000-0002-0859-3854 surname: McClenaghan fullname: McClenaghan, Conor organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO – sequence: 3 givenname: Manish orcidid: 0000-0003-1073-0376 surname: Aggarwal fullname: Aggarwal, Manish organization: Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO – sequence: 4 givenname: Hongjie surname: Gu fullname: Gu, Hongjie organization: Division of Statistics Washington University School of Medicine St. Louis MO – sequence: 5 givenname: Maria S. orcidid: 0000-0003-2048-472X surname: Remedi fullname: Remedi, Maria S. organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Medicine, Division of Endocrinology Washington University School of Medicine St. Louis MO – sequence: 6 givenname: Dorothy K. orcidid: 0000-0001-7425-6322 surname: Grange fullname: Grange, Dorothy K. organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Pediatrics, Division of Genetics Washington University School of Medicine St. Louis MO – sequence: 7 givenname: Colin G. orcidid: 0000-0002-4929-2134 surname: Nichols fullname: Nichols, Colin G. organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36515236$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kkFvFCEcxYmpsbXt2Zvh6GW3wAzMcDGZbGy3ZpM22nolDDC7NDMwAmOzNz-Cn9FPIuu2pm0iF8if934vgfcWHDjvDADvMJpjzPDZ52bZzDEhc0SqghWvwBFBZTXjvEYHT86H4DTGO5QXyzrK34DDglFMScGOQGrgrbPfJwOXdr35_fPX1ZTGKcGFDNpKBZfb0YQU_LjZwuuNcT7lAWyCjdat4XnwA1z5e_h1G5MZrILfZFRTLwP8YqKNSTploHUZ59KUVU5nhzkBrzvZR3P6sB-D2_NPN4vlbHV1cbloVjNVUp5mvK0Z55qUpEVtpWusOmp4rbXkjBPNMC3KVhe4qquad6STtGYaUa0N0ZyXujgGl3uu9vJOjMEOMmyFl1b8HfiwFjIkq3ojOm46VaCWIIbLSrIWMc1MiXKYLLmWmfVxzxqndjBaGZeC7J9Bn984uxFr_0Pwitc1QRnw4QEQfH7vmMRgozJ9L53xUxSkoiXNf4Z30vdPs_6FPH5bFtC9QAUfYzCdUDbJZP0u2vYCI7FriNg1ROSGiH1Dsu_she8R_T_HH352v4E |
| CitedBy_id | crossref_primary_10_1186_s12944_024_02232_8 crossref_primary_10_1002_ajmg_a_63815 crossref_primary_10_1124_jpet_123_001659 crossref_primary_10_1007_s00246_024_03528_3 crossref_primary_10_1093_function_zqad017 crossref_primary_10_1113_JP287415 crossref_primary_10_1038_s41598_025_00547_9 crossref_primary_10_1093_function_zqae027 |
| Cites_doi | 10.1111/apa.14110 10.1016/j.jacc.2006.07.047 10.1016/j.ajhg.2012.04.014 10.1016/j.euje.2005.12.014 10.1073/pnas.1606465113 10.1016/j.ejmg.2013.09.009 10.1002/ajmg.a.33885 10.1093/qjmed/hcn147 10.1002/humu.22555 10.1161/01.CIR.68.2.302 10.1155/2016/5720758 10.1161/CIRCULATIONAHA.109.192065 10.1016/S0735-1097(97)00344-6 10.1093/function/zqaa004 10.1016/j.jacc.2016.05.043 10.1172/jci.insight.121153 10.1212/WNL.0000000000002861 10.1002/ajmg.a.36228 10.1016/j.echo.2016.08.013 10.1038/ng.2324 10.1016/j.echo.2003.12.005 10.1016/0002-9149(86)90771-X 10.1002/ajmg.a.31348 10.1016/j.echo.2009.08.014 10.1161/hc0102.101396 10.1161/CIRCRESAHA.108.178186 10.1016/j.hrthm.2015.06.042 10.1161/01.CIR.97.19.1907 10.1161/01.STR.25.1.11 10.1016/0002-9149(87)91189-1 10.1080/00913847.2019.1568769 10.1016/j.echo.2009.03.003 10.1172/JCI130571 10.1002/ajmg.c.31753 10.1007/s00421-016-3506-8 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. |
| Copyright_xml | – notice: 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1161/JAHA.122.027363 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | High‐Output Cardiac Hypertrophy in Cantu Syndrome |
| EISSN | 2047-9980 |
| ExternalDocumentID | oai_doaj_org_article_f9efc30b206147a6b06d6e40ddaa49da PMC9798820 36515236 10_1161_JAHA_122_027363 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K99 HL150277 – fundername: NICHD NIH HHS grantid: R21 HD103347 – fundername: NHLBI NIH HHS grantid: R00 HL150277 – fundername: NHLBI NIH HHS grantid: R35 HL140024 – fundername: ; grantid: CH‐MD‐II‐2015‐488 – fundername: Center for the Investigation of Membrane Excitability Diseases Pilot and Feasibility program grantid: CIMED‐14‐03 |
| GroupedDBID | 0R~ 1OC 53G 5VS 8-1 AAMMB AAYXX AAZKR ACGFO ACXQS ADBBV ADKYN ADZMN AEFGJ AEGXH AENEX AGXDD AIAGR AIDQK AIDYY ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BCNDV CITATION DIK EBS EMOBN GODZA GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 RAH RNS RPM WIN 24P ACCMX CGR CUY CVF ECM EIF NPM RHF 7X8 5PM |
| ID | FETCH-LOGICAL-c459t-9b8699d242b0b7d81cf5e98dda9692d61534bd3178789f2fa586d05dde2d994d3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000901793400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2047-9980 |
| IngestDate | Fri Oct 03 12:44:02 EDT 2025 Tue Nov 04 02:06:50 EST 2025 Fri Sep 05 10:58:01 EDT 2025 Wed Feb 19 02:23:27 EST 2025 Sat Nov 29 05:05:04 EST 2025 Tue Nov 18 21:23:42 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 24 |
| Keywords | heart failure ABCC9 cardiomegaly high‐output state echocardiography |
| Language | English |
| License | This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c459t-9b8699d242b0b7d81cf5e98dda9692d61534bd3178789f2fa586d05dde2d994d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 For Sources of Funding and Disclosures, see page 11. |
| ORCID | 0000-0003-2048-472X 0000-0003-1073-0376 0000-0001-7425-6322 0000-0002-4929-2134 0000-0002-0859-3854 |
| OpenAccessLink | https://doaj.org/article/f9efc30b206147a6b06d6e40ddaa49da |
| PMID | 36515236 |
| PQID | 2754504710 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f9efc30b206147a6b06d6e40ddaa49da pubmedcentral_primary_oai_pubmedcentral_nih_gov_9798820 proquest_miscellaneous_2754504710 pubmed_primary_36515236 crossref_citationtrail_10_1161_JAHA_122_027363 crossref_primary_10_1161_JAHA_122_027363 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-12-20 |
| PublicationDateYYYYMMDD | 2022-12-20 |
| PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Hoboken |
| PublicationTitle | Journal of the American Heart Association |
| PublicationTitleAlternate | J Am Heart Assoc |
| PublicationYear | 2022 |
| Publisher | John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley and Sons Inc – name: Wiley |
| References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 |
| References_xml | – ident: e_1_3_2_13_2 doi: 10.1111/apa.14110 – ident: e_1_3_2_14_2 doi: 10.1016/j.jacc.2006.07.047 – ident: e_1_3_2_7_2 doi: 10.1016/j.ajhg.2012.04.014 – ident: e_1_3_2_18_2 doi: 10.1016/j.euje.2005.12.014 – ident: e_1_3_2_12_2 doi: 10.1073/pnas.1606465113 – ident: e_1_3_2_4_2 doi: 10.1016/j.ejmg.2013.09.009 – ident: e_1_3_2_9_2 doi: 10.1002/ajmg.a.33885 – ident: e_1_3_2_35_2 doi: 10.1093/qjmed/hcn147 – ident: e_1_3_2_5_2 doi: 10.1002/humu.22555 – ident: e_1_3_2_23_2 doi: 10.1161/01.CIR.68.2.302 – ident: e_1_3_2_3_2 doi: 10.1155/2016/5720758 – ident: e_1_3_2_2_2 doi: 10.1161/CIRCULATIONAHA.109.192065 – ident: e_1_3_2_20_2 doi: 10.1016/S0735-1097(97)00344-6 – ident: e_1_3_2_27_2 doi: 10.1093/function/zqaa004 – ident: e_1_3_2_30_2 doi: 10.1016/j.jacc.2016.05.043 – ident: e_1_3_2_28_2 doi: 10.1172/jci.insight.121153 – ident: e_1_3_2_33_2 doi: 10.1212/WNL.0000000000002861 – ident: e_1_3_2_34_2 doi: 10.1002/ajmg.a.36228 – ident: e_1_3_2_24_2 doi: 10.1016/j.echo.2016.08.013 – ident: e_1_3_2_6_2 doi: 10.1038/ng.2324 – ident: e_1_3_2_21_2 doi: 10.1016/j.echo.2003.12.005 – ident: e_1_3_2_15_2 doi: 10.1016/0002-9149(86)90771-X – ident: e_1_3_2_8_2 doi: 10.1002/ajmg.a.31348 – ident: e_1_3_2_29_2 doi: 10.1016/j.echo.2009.08.014 – ident: e_1_3_2_19_2 doi: 10.1161/hc0102.101396 – ident: e_1_3_2_26_2 doi: 10.1161/CIRCRESAHA.108.178186 – ident: e_1_3_2_11_2 doi: 10.1016/j.hrthm.2015.06.042 – ident: e_1_3_2_17_2 doi: 10.1161/01.CIR.97.19.1907 – ident: e_1_3_2_25_2 doi: 10.1161/01.STR.25.1.11 – ident: e_1_3_2_22_2 doi: 10.1016/0002-9149(87)91189-1 – ident: e_1_3_2_32_2 doi: 10.1080/00913847.2019.1568769 – ident: e_1_3_2_16_2 doi: 10.1016/j.echo.2009.03.003 – ident: e_1_3_2_36_2 doi: 10.1172/JCI130571 – ident: e_1_3_2_10_2 doi: 10.1002/ajmg.c.31753 – ident: e_1_3_2_31_2 doi: 10.1007/s00421-016-3506-8 |
| SSID | ssj0000627359 |
| Score | 2.3617287 |
| Snippet | Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e027363 |
| SubjectTerms | ABCC9 Adenosine Triphosphate Adolescent Adult cardiomegaly Cardiomegaly - genetics Child Child, Preschool echocardiography Female heart failure Heart Failure - complications high‐output state Humans Hypertrichosis - genetics Hypertrophy, Left Ventricular - complications Hypertrophy, Left Ventricular - diagnostic imaging Hypertrophy, Left Ventricular - genetics KATP Channels Male Original Research Osteochondrodysplasias - genetics Phenotype Vascular Resistance Young Adult |
| Title | A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36515236 https://www.proquest.com/docview/2754504710 https://pubmed.ncbi.nlm.nih.gov/PMC9798820 https://doaj.org/article/f9efc30b206147a6b06d6e40ddaa49da |
| Volume | 11 |
| WOSCitedRecordID | wos000901793400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ (Directory of Open Access Journals) customDbUrl: eissn: 2047-9980 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000627359 issn: 2047-9980 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2047-9980 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000627359 issn: 2047-9980 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 2047-9980 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000627359 issn: 2047-9980 databaseCode: WIN dateStart: 20120101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagQohLVX4bCpWROHBJ63Ucx3Ncqq5WiJYKUbQ3K44dNRIkVTYLN8Qj8Iw8CWM7Xe0iEBcuOSSOY3nGM9_Yk28IeakyUzlRo_UTgqeiLl2KKNylxvm65sJwsCYUmyjOz9ViARcbpb58TlikB44Td1yDq6uMGe5Dl6KUhkkrnWDWlqUAG6ARop6NYCraYHTLOYxcPohqjt9M537jjx95AheZbbmhwNb_J4j5e6bkhuuZ7ZHdETPSaRzrfXLLtQ_I3bPxVPwhGab0MvCwUp-18fP7j3er4Xo10JMg_YrOMdbsh77DGaUXV67t_L4rdtf4fQI667vP9G33lUby8qaiH8fsVPreLT28RL2gTYvdoX_CVpHi4BG5nJ1-OJmnYzWFtBI5DCkYJQEsumTDTGHVpKpzBwrnESRw64GfMBbhhCoU1LwucyUty9H8cQsgbPaY7LRd6_YJlZxZ4CWzNdQCTZ4plGTC5jbLLZRykpCjm8nV1Ug17itefNIh5JAT7aWhURo6SiMhr9YvXEeWjb83fe2ltW7m6bHDDVQaPSqN_pfSJOTFjaw1Lid_RlK2rlstNS8QUjL02CwhT6Ls15_KfNl4nsmEFFtasTWW7SdtcxUou8HTwnH29H8M_oDc4_4fjAlHE_eM7Az9yj0nd6ovQ7PsD8ntYqEOw2rA69m3018wShH1 |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Unique+High%E2%80%90Output+Cardiac+Hypertrophy+Phenotype+Arising+From+Low+Systemic+Vascular+Resistance+in+Cantu+Syndrome&rft.jtitle=Journal+of+the+American+Heart+Association&rft.au=Singh%2C+Gautam+K.&rft.au=McClenaghan%2C+Conor&rft.au=Aggarwal%2C+Manish&rft.au=Gu%2C+Hongjie&rft.date=2022-12-20&rft.pub=John+Wiley+and+Sons+Inc&rft.eissn=2047-9980&rft.volume=11&rft.issue=24&rft_id=info:doi/10.1161%2FJAHA.122.027363&rft_id=info%3Apmid%2F36515236&rft.externalDocID=PMC9798820 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9980&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9980&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9980&client=summon |